Immune responses to SARS-CoV-2 mRNA vaccination in people with idiopathic CD4 lymphopenia
Description
CONCLUSIONS: Patients with ICL and CD4 counts >100 cells/μL can mount vigorous humoral and cellular immune responses to SARS-CoV-2 vaccination; however, patients with more severe CD4 lymphopenia have blunted vaccine-induced immunity and may require